Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Pradeep

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 10, 2022
Epidemiological and clinical characterization of dengue virus serotypes during 2017-2019 in southern Kerala, IndiaArya Rahul, Prasanta Saini, Mathew J Valamparampil, et al.
Vaccine|September 4, 2023
Immunogenicity and safety of Havisure<sup>TM</sup> vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority studySai Krishna Susarla, Madhu Gupta, Kheya Ghosh Uttam, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 3, 2021
Nation-wide vector surveillance on Zika and Dengue did not indicate transmission of the American lineage-pandemic Zika virus in IndiaN Pradeep Kumar, Ashwani Kumar, D Panneer, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 10, 2022
Epidemiological and clinical characterization of dengue virus serotypes during 2017-2019 in southern Kerala, IndiaArya Rahul, Prasanta Saini, Mathew J Valamparampil, et al.
Vaccine|September 4, 2023
Immunogenicity and safety of Havisure<sup>TM</sup> vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority studySai Krishna Susarla, Madhu Gupta, Kheya Ghosh Uttam, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 3, 2021
Nation-wide vector surveillance on Zika and Dengue did not indicate transmission of the American lineage-pandemic Zika virus in IndiaN Pradeep Kumar, Ashwani Kumar, D Panneer, et al.
Pageof 6